GEORGE HUTTON to Recurrence
This is a "connection" page, showing publications GEORGE HUTTON has written about Recurrence.
Connection Strength
0.606
-
Comparative effectiveness of high-efficacy and moderate efficacy disease-modifying agents in reducing the annualized relapse rates among multiple sclerosis patients in the United States. Prev Med. 2025 Jan; 190:108180.
Score: 0.179
-
Frequency, characteristics, predictors and treatment of relapsing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Mult Scler Relat Disord. 2024 Jul; 87:105672.
Score: 0.172
-
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis. Mult Scler Relat Disord. 2024 May; 85:105539.
Score: 0.171
-
Elsberg syndrome following acute immunosuppressive treatment for multiple sclerosis relapse. Mult Scler Relat Disord. 2022 Feb; 58:103498.
Score: 0.037
-
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Mult Scler Relat Disord. 2020 Aug; 43:102146.
Score: 0.033
-
Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008 Nov; 122(5):e1039-47.
Score: 0.015